![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Mayo patient with life-threatening multidrug-resistant infection ...
2022年5月9日 · Mayo Clinic has established partnerships with several entities for phage biomanufacturing, with ultimate plans to establish phage biomanufacturing on site. "Mark’s case was quite challenging, given the aggressive organism (MRSA), the failure to respond to multiple prior surgical interventions, and extensive allergies to antibiotics which ...
In a first, Mayo Clinic treats cardiology patient with phage therapy
2023年3月8日 · Next steps for phage therapy. Dr. Suh is working to make phage therapy more broadly applicable, including plans to treat more cardiology patients. She also is launching two clinical trials in 2023 to continue to evaluate phage therapy in the treatment of prosthetic joint infections and pressure injury wounds.
Phage therapy shows potential for treating prosthetic joint infections
2020年7月23日 · ROCHESTER, Minn. — Bacteriophages, or phages, may play a significant role in treating complex bacterial infections in prosthetic joints, according to new Mayo Clinic research. The findings suggest phage therapy could provide a potential treatment for managing such infections, including those involving antibiotic-resistant microbes. The research is published in the July issue of Clinical ...
7 ways Mayo Clinic is leading to cure, connect and transform …
2020年2月11日 · Mayo is also supporting a new phage therapy program to offer a potential life-saving alternative to antibiotics. Phages are naturally occurring viruses that target and kill specific bacterial cells, including those that have grown resistant to multiple antibiotics.
Celebrating Mayo Clinic women in medicine on International …
2021年3月8日 · Dr. Suh has a special interest in bacteriophages as a novel therapeutic for the treatment of infections, particularly multi-drug resistant and biofilm-mediated infections. She treated Mayo Clinic’s first phage therapy patient and is heading efforts to create the Mayo Clinic Phage Therapy Program and run clinical trials.
Mayo Clinic Q and A: Understanding nasal polyps
2019年10月29日 · DEAR MAYO CLINIC: What causes nasal polyps, and do they always require removal? If they are removed, is there a chance they might come back? ANSWER: Nasal polyps form in the nasal passages and sinuses as a result of chronic inflammation called chronic rhinosinusitis. When they are small, nasal polyps may not cause any symptoms […]
Science Saturday: A year of new directions and advancements for ...
2022年1月29日 · Phage-based therapies — viruses that attack multiple drug-resistant infections. Extracellular vesicles — secreted by natural or engineered cells, they can act as drug, protein or gene transporters. Synthetic biology — redesigning function of organisms to fit medical needs. Research that advances the practice
A new name for Center for Regenerative Medicine
2022年8月30日 · Mayo Clinic's Center for Regenerative Medicine has been renamed the Center for Regenerative Biotherapeutics. The name change reflects Mayo's new strategic focus: manufacturing next-generation biotherapeutics for patients. The new name emphasizes how regenerative medicine at Mayo Clinic has evolved to advance groundbreaking discoveries toward curative products — biotherapeutics — for ...
Science Saturday: A robotic GPS for targeting, delivering …
2021年10月2日 · A remote-controlled bronchoscope that acts like a GPS system hunts down hard to find lung masses and accurately biopsies them, according to a Mayo Clinic collaborative study. This multisite research, which is published in Annals of Thoracic Surgery, lays the foundation for precisely finding early stage cancer and targeting it with regenerative biotherapeutics needed to …
Scientists discover autoimmune disease associated with testicular ...
2019年7月3日 · A UCSF team led by Joe DeRisi, Ph.D., a biochemist and co-president of Chan Zuckerberg Biohub, and Michael Wilson, M.D., neurologist and member of the UCSF Weill Institute for Neurosciences, developed a customized version of phage technology that identified KLHL11 as the target for testicular cancer-associated paraneoplastic encephalitis based ...